Penumbra (PEN) Return on Capital Employed Growth (3y) (2018 - 2026)
Penumbra (PEN) Return on Capital Employed Growth (3y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.46 Bn | 193.86 Bn | 7.27 Bn | -236.00 |
| 2 | Stryker | 127.41 Bn | 123.93 Bn | 4.50 Bn | 281.00 |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 145.00 |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 446.00 |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.69 Bn | 1.35 Bn | -433.00 |
| 6 | Dexcom | 34.30 Bn | 32.35 Bn | 830.00 Mn | 1,627.00 |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | -62.00 |
| 8 | Koninklijke Philips | 26.35 Bn | 23.02 Bn | 4.55 Bn | - |
| 9 | Steris | 23.04 Bn | 22.55 Bn | 684.20 Mn | 370.00 |
| 10 | Penumbra | 12.78 Bn | 12.13 Bn | 264.94 Mn | 815.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 815.00 |
| Mar 31, 2026 | 987.00 |
| Dec 31, 2025 | 1,130.00 |
| Sep 30, 2025 | 1,449.00 |
| Jun 30, 2025 | 1,382.00 |
| Mar 31, 2025 | 486.00 |
| Dec 31, 2024 | 145.00 |
| Mar 31, 2024 | 911.00 |
| Dec 31, 2023 | 1,088.00 |
| Sep 30, 2023 | 719.00 |
| Jun 30, 2023 | 184.00 |
| Mar 31, 2023 | -494.00 |
| Dec 31, 2022 | -815.00 |
| Sep 30, 2022 | -1,176.00 |
| Jun 30, 2022 | -496.00 |
| Mar 31, 2022 | -351.00 |
| Dec 31, 2021 | -57.00 |
| Mar 31, 2021 | -530.00 |
| Dec 31, 2020 | -576.00 |
| Sep 30, 2020 | -288.00 |